跳至主要内容
临床试验/CTRI/2026/01/100148
CTRI/2026/01/100148招募中2 期

Effect of Ozone Therapy as an adjuvant to Conventional Medicine on HbA1C, FBS, PPBS, and QOL in Type 2 Diabetes Mellitus

Dr. Arkaprava Das Adhikary1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2026年1月12日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
102
试验地点
1

研究概览

简要总结

A study to find the impact of ozone therapy as an adjunct treatment on glycated hemoglobin among patients with type 2 diabetes mellitus and to test the hypothesis of how ozone therapy helps in the management of Type 2 diabetes mellitus.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patient is willing to participate History of type 2 diabetes mellitus for the past 1 year Depending on oral or parenteral hypoglycemic medications Zubrods performance status is 0–2.

排除标准

  • Acute alcohol intoxication A recent myocardial infarction Haemorrhage from any organ Pregnancy Hyperthyroidis Thrombocytopenia Severe anaemia Ozone allergy Serious Cardio-Vascular instability Patients on Angiotensin-converting enzyme(ACE) inhibitors G6PD deficiency.

研究者

发起方
Dr. Arkaprava Das Adhikary
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Arkaprava Das Adhikary

Maharishi Aurobindo Subharti College and Hospital of Naturopathy and Yogic Sciences

研究点 (1)

Loading locations...

相似试验

Effect of Ozone Therapy on Diabetes Patients | 临床试验